prexanil combi 4 mg/1,25 mg tablete
servier pharma d.o.o. - indapamid; perindopril - tableta - indapamid 1,25 mg / 1 tableta perindopril3,34 mg / 1 tableta; perindopril 3,34 mg / 1 tableta - perindopril in diuretiki
tertensifkomb 10 mg/2,5 mg filmsko obložene tablete
servier pharma d.o.o. - indapamid, perindopril - filmsko obložena tableta - indapamid 2,5 mg / 1 tableta; perindopril 6,79 mg / 1 tableta - perindopril in diuretiki
imprida
novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravljenje esencialne hipertenzije. imprida je indicirana pri bolnikih, katerih krvni tlak ni ustrezno nadzorovan na amlodipine ali valsartan monotherapy.
olumiant
eli lilly nederland b.v. - baricitinib - artritis, revmatoidni - imunosupresivi - rheumatoid arthritisbaricitinib is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease modifying anti rheumatic drugs (dmards). zdravilo olumiant se lahko uporablja kot monoterapija ali v kombinaciji z metotreksatom. atopic dermatitisolumiant is indicated for the treatment of moderate to severe atopic dermatitis in adult and paediatric patients 2 years of age and older who are candidates for systemic therapy. alopecia areatabaricitinib is indicated for the treatment of severe alopecia areata in adult patients (see section 5. juvenile idiopathic arthritisbaricitinib is indicated for the treatment of active juvenile idiopathic arthritis in patients 2 years of age and older who have had an inadequate response or intolerance to one or more prior conventional synthetic or biologic dmards:- polyarticular juvenile idiopathic arthritis (polyarticular rheumatoid factor positive [rf+] or negative [rf-], extended oligoarticular),- enthesitis related arthritis, and- juvenile psoriatic arthritis. baricitinib may be used as monotherapy or in combination with methotrexate.
elyrno 20 mg/10 mg filmsko obložene tablete
krka, d.d., novo mesto - enalapril, lerkanidipin - filmsko obložena tableta - enalapril 15,29 mg / 1 tableta; lerkanidipin 9,44 mg / 1 tableta - enalapril in lerkanidipin
elyrno 10 mg/10 mg filmsko obložene tablete
krka, d.d., novo mesto - enalapril, lerkanidipin - filmsko obložena tableta - enalapril 7,64 mg / 1 tableta; lerkanidipin 9,44 mg / 1 tableta - enalapril in lerkanidipin
elyrno 20 mg/10 mg filmsko obložene tablete
krka, d.d., novo mesto - enalapril, lerkanidipin - filmsko obložena tableta - enalapril 15,29 mg / 1 tableta; lerkanidipin 9,44 mg / 1 tableta - enalapril in lerkanidipin
elyrno 10 mg/10 mg filmsko obložene tablete
krka, d.d., novo mesto - enalapril, lerkanidipin - filmsko obložena tableta - enalapril 7,64 mg / 1 tableta; lerkanidipin 9,44 mg / 1 tableta - enalapril in lerkanidipin
phoxilium 1,2 mmol/l fosfata raztopina za hemodializo/hemofiltracijo
gambro lundia ab - raztopina za hemodializo/hemofiltracijo - zdravila za filtracijo krvi
rasilamlo
novartis europharm ltd - aliskiren, amlodipine - hipertenzija - sredstva, ki delujejo na sistem renin-angiotenzin - zdravilo rasilamlo je indicirano za zdravljenje esencialne hipertenzije pri odraslih bolnikih, pri katerih krvni tlak ni ustrezno nadzorovan z uporabo aliskirena ali amlodipina.